Cargando…

Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus

The H7N9 viruses have been circulating for six years. The insertion of a polybasic cleavage site in the haemagglutinin (HA) protein of H7N9 has resulted in the emergence of a highly pathogenic (HP) avian influenza virus. Currently, there are limited studies on neutralizing monoclonal antibodies(mAbs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fan, Xiao, Yixin, Lu, Rufeng, Chen, Bin, Liu, Fumin, Wang, Liyan, Yao, Hangping, Wu, Nanping, Wu, Haibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144216/ https://www.ncbi.nlm.nih.gov/pubmed/32193996 http://dx.doi.org/10.1080/22221751.2020.1742076

Ejemplares similares

Antigen-capture ELISA and immunochromatographic test strip to detect the H9N2 subtype avian influenza virus rapidly based on monoclonal antibodies
por: Xiao, Yixin, et al.
Publicado: (2021)

Isolation and characterization of novel reassortant H6N1 avian influenza viruses from chickens in Eastern China
por: Wu, Haibo, et al.
Publicado: (2018)

Development and evaluation of a TaqMan MGB RT-PCR assay for detection of H5 and N8 subtype influenza virus
por: Yang, Fan, et al.
Publicado: (2020)

A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
por: Li, Jingxin, et al.
Publicado: (2022)

Characterization of Novel Reassortant Influenza A (H5N2) Viruses Isolated from Poultry in Eastern China, 2015
por: Wu, Haibo, et al.
Publicado: (2017)

Allosteric Neutralization by Human H7N9 Antibodies
por: Jia, Manxue, et al.
Publicado: (2023)

Comparison of a New Gold Immunochromatographic Assay for the Rapid Diagnosis of the Novel Influenza A (H7N9) Virus with Cell Culture and a Real-Time Reverse-Transcription PCR Assay
por: Jin, Changzhong, et al.
Publicado: (2014)

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
por: Nogales, Aitor, et al.
Publicado: (2018)

Genetic and molecular characterization of H9N2 and H5 avian influenza viruses from live poultry markets in Zhejiang Province, eastern China
por: Wu, Haibo, et al.
Publicado: (2015)

Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
por: Yasugi, Mayo, et al.
Publicado: (2013)

Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies
por: Du, Lanying, et al.
Publicado: (2010)

Safe Pseudovirus-based Assay for Neutralization Antibodies against Influenza A(H7N9) Virus
por: Qiu, Chao, et al.
Publicado: (2013)

Broad neutralizing activity of a human monoclonal antibody against H7N9 strains from 2013 to 2017
por: Chen, Cong, et al.
Publicado: (2018)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man
por: Okada, Jun, et al.
Publicado: (2011)

Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2
por: Chu, Xiaoyu, et al.
Publicado: (2023)

Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases
por: Meng, Weixu, et al.
Publicado: (2013)

Neutralizing monoclonal antibodies for treatment of COVID-19
por: Taylor, Peter C., et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Longevity of protective immune responses induced by a split influenza A (H7N9) vaccine mixed with MF59 adjuvant in BALB/c mice
por: Ou, Huilin, et al.
Publicado: (2017)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

A multiplex TaqMan real-time RT-PCR assay for the simultaneous detection of H4, H6, and H10 avian influenza viruses
por: Yang, Fan, et al.
Publicado: (2023)

A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
por: Clementi, Nicola, et al.
Publicado: (2011)

Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses
por: Vigil, Adam, et al.
Publicado: (2018)

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection
por: Tan, Gene S., et al.
Publicado: (2016)

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
por: Krey, Thomas, et al.
Publicado: (2013)

Preclinical evaluation of the safety and pathogenicity of a live attenuated recombinant influenza A/H7N9 seed strain and corresponding MF59-adjuvanted split vaccine
por: Ou, Huilin, et al.
Publicado: (2016)

Novel Reassortant Influenza A(H5N8) Viruses in Domestic Ducks, Eastern China
por: Wu, Haibo, et al.
Publicado: (2014)

Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
por: Drozdowski, Brian, et al.
Publicado: (2010)

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
por: Liu, Ling, et al.
Publicado: (2016)

Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33
por: Okragly, Angela J, et al.
Publicado: (2021)

Humanization and Characterization of an Anti-Ricin Neutralization Monoclonal Antibody
por: Hu, Wei-Gang, et al.
Publicado: (2012)

An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies
por: Ahmadi, Shirin, et al.
Publicado: (2020)

Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
por: Jaworski, Juan Pablo
Publicado: (2021)

Neutralizing monoclonal antibodies against highly pathogenic coronaviruses
por: Xiang, Rong, et al.
Publicado: (2022)

Amino Acid Substitutions HA A150V, PA A343T, and PB2 E627K Increase the Virulence of H5N6 Influenza Virus in Mice
por: Peng, Xiuming, et al.
Publicado: (2018)

A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7
por: Wang, Rong, et al.
Publicado: (2019)

Tackling influenza with broadly neutralizing antibodies
por: Corti, Davide, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pe6eaq2p61g9v9lgn7t4ac1rj0